Get the Stockscreener App
64.45
2.91%
-1.93
After Hours:
64.45
Hologic Inc stock is traded at $64.45, with a volume of 1.01M.
It is down -2.91% in the last 24 hours and down -5.15% over the past month.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
See More
Previous Close:
$66.38
Open:
$66.05
24h Volume:
1.01M
Relative Volume:
0.53
Market Cap:
$14.33B
Revenue:
$4.03B
Net Income/Loss:
$556.70M
P/E Ratio:
27.19
EPS:
2.37
Net Cash Flow:
$970.10M
1W Performance:
-3.46%
1M Performance:
-5.15%
6M Performance:
+5.48%
1Y Performance:
-19.86%
1-Day Range:
$64.38
$66.25
1-Week Range:
$64.38
$66.97
52-Week Range:
$51.90
$84.39
Hologic Inc Stock (HOLX) Company Profile
Name
Hologic Inc
Sector
Industry
Phone
(508) 263-2900
Address
250 CAMPUS DRIVE, MARLBOROUGH, MA
Compare HOLX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
64.45 | 14.57B | 4.03B | 556.70M | 970.10M | 2.37 |
|
ISRG
Intuitive Surgical Inc
|
449.68 | 161.31B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
186.84 | 54.01B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
270.14 | 39.60B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
78.29 | 38.49B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
253.50 | 18.35B | 2.96B | 487.70M | 344.00M | 6.68 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-18-25 | Upgrade | Argus | Hold → Buy |
| Aug-06-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jul-09-25 | Upgrade | Citigroup | Neutral → Buy |
| May-27-25 | Reiterated | Needham | Hold |
| Mar-03-25 | Downgrade | Argus | Buy → Hold |
| Feb-06-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Feb-03-25 | Downgrade | Needham | Buy → Hold |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-10-24 | Initiated | Jefferies | Hold |
| Dec-10-24 | Reiterated | Needham | Buy |
| Oct-01-24 | Downgrade | Citigroup | Buy → Neutral |
| Jun-27-24 | Initiated | Stephens | Overweight |
| Apr-03-24 | Upgrade | Citigroup | Neutral → Buy |
| Jul-14-23 | Upgrade | Needham | Hold → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Jul-20-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-20-22 | Initiated | UBS | Neutral |
| Jul-18-22 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-15-21 | Downgrade | Citigroup | Buy → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Oct-14-21 | Initiated | Redburn | Neutral |
| Jul-06-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-20-20 | Downgrade | Needham | Buy → Hold |
| Nov-05-20 | Reiterated | Needham | Buy |
| Jun-30-20 | Upgrade | Cowen | Market Perform → Outperform |
| Jun-03-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-30-20 | Reiterated | Needham | Buy |
| Apr-30-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Apr-07-20 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-27-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-13-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Aug-01-19 | Reiterated | Needham | Buy |
| May-02-19 | Reiterated | Needham | Buy |
| Jan-31-19 | Reiterated | Needham | Buy |
| Jan-02-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-09-18 | Initiated | UBS | Neutral |
| Sep-13-18 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Hologic Inc Stock (HOLX) Latest News
Does Hologic (HOLX) Have a Compelling Valuation? - ca.finance.yahoo.com
Breast Conserving Surgery Market May See a Big Move | Major Giants- Hologic, Merit Medical Systems, STERRLAB - openPR.com
Hologic (HOLX) Stock Sinks As Market Gains: What You Should Know - sharewise.com
Hologic's 2025 Outlook Improves on Strong Q3, Easing Tariff Headwinds - The Globe and Mail
Hologic, Inc. $HOLX Shares Sold by AQR Capital Management LLC - MarketBeat
Baird Financial Group Inc. Sells 47,449 Shares of Hologic, Inc. $HOLX - MarketBeat
Alliancebernstein L.P. Has $147.09 Million Stock Position in Hologic, Inc. $HOLX - MarketBeat
What are the risks of holding Hologic Inc.Share Buyback & Daily Entry Point Alerts - Lancaster City Council
Hologic at Morgan Stanley Conference: Navigating Growth and Challenges By Investing.com - Investing.com South Africa
Hologic at Morgan Stanley Conference: Navigating Growth and Challenges - Investing.com
Five Women File Joint Lawsuit Over BioZorb Breast Implant Side Effects - AboutLawsuits.com
Amundi Sells 423,165 Shares of Hologic, Inc. $HOLX - MarketBeat
Gotham Asset Management LLC Has $10.54 Million Stock Holdings in Hologic, Inc. $HOLX - MarketBeat
Wall Street Zen Upgrades Hologic (NASDAQ:HOLX) to Buy - MarketBeat
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know - Yahoo Finance
RSI Suggests Rebound May Be Near in Hologic Inc.Weekly Stock Analysis & AI Powered Market Trend Analysis - beatles.ru
Is Hologic Inc. stock a buy or sellWeekly Trend Summary & Daily Profit Maximizing Tips - beatles.ru
Sandler Capital Management Purchases 9,290 Shares of Hologic, Inc. $HOLX - MarketBeat
Hologic, Inc. $HOLX Shares Purchased by Vident Advisory LLC - MarketBeat
Can Hologic Inc. grow without dilutionExit Point & Consistent Income Trade Recommendations - classian.co.kr
Ranking Hologic Inc. among high performing stocks via toolsInsider Selling & Reliable Breakout Stock Forecasts - Newser
Buried Complaints Left a Damaging Cancer Device on the Market - Bloomberg.com
Hologic, Inc. $HOLX Shares Bought by BNP Paribas Financial Markets - MarketBeat
What’s the fair value of Hologic Inc. stockJuly 2025 Earnings & Low Volatility Stock Suggestions - خودرو بانک
Published on: 2025-09-05 14:48:15 - Newser
Published on: 2025-09-05 06:17:32 - Newser
Exit strategy if you’re trapped in Hologic Inc.July 2025 Recap & Fast Gain Swing Alerts - Newser
Is Hologic Inc. stock a hidden gemQuarterly Trade Report & Stepwise Trade Signal Guides - classian.co.kr
What recovery options are there for Hologic Inc.Market Volume Report & Real-Time Chart Breakout Alerts - Newser
Stock Analysis | Hologic OutlookA Technical Downturn Amid Optimistic Analysts - AInvest
Alamea Verwaltungs GmbH Makes New $702,000 Investment in Hologic, Inc. $HOLX - MarketBeat
Will Hologic Inc. outperform the marketJuly 2025 Price Swings & Verified Entry Point Signals - Newser
Strategies to average down on Hologic Inc.2025 Trading Volume Trends & Accurate Entry/Exit Alerts - Newser
Can trapped investors hope for a rebound in Hologic IncPortfolio Growth Summary & Daily Technical Stock Forecast Reports - Newser
Will Hologic Inc. stock go up in YEARJuly 2025 Highlights & Reliable Breakout Stock Forecasts - خودرو بانک
Hologic's Panther Fusion Signals More Molecular Diagnostics Upside - Nasdaq
Body Fat Measurement Market Set to Explode in Growth by 2025-2032 - openPR.com
What machine learning models say about Hologic Inc.July 2025 Highlights & Free Risk Controlled Daily Trade Plans - Newser
Is Hologic Inc. stock influenced by commodity prices2025 Earnings Surprises & Risk Adjusted Buy and Sell Alerts - خودرو بانک
Hologic to Webcast Presentation at the 23rd Annual Morgan Stanley Global Healthcare Conference - BioSpace
Sectors Driving Future Growth for Hologic Inc. StockQuarterly Portfolio Summary & Weekly Setup with High ROI Potential - Newser
Will Hologic Inc. benefit from macro trendsNew Guidance & AI Driven Stock Movement Reports - Newser
Can trapped investors hope for a rebound in Hologic Inc.July 2025 WrapUp & Advanced Swing Trade Entry Plans - Newser
Pus, Pain and Infections: A Faulty Implant Tormented Cancer Patients for Years - Bloomberg.com
Hologic (HOLX) Gets a Buy from RBC Capital - The Globe and Mail
Does Hologic Inc. have high return on assetsOptions Play & Long-Term Safe Investment Ideas - khodrobank.com
Can momentum traders help lift Hologic Inc.Weekly Trend Summary & Risk Controlled Stock Pick Alerts - Newser
Combining machine learning predictions for Hologic IncFed Meeting & Reliable Price Breakout Signals - Newser
RBC Raises Price Target on Hologic to $94 From $87, Keeps Outperform Rating - MarketScreener
What Fibonacci levels say about Hologic Inc. reboundProfit Target & Risk Managed Investment Strategies - Newser
Applying Wyckoff theory to Hologic Inc. stock2025 Volatility Report & Safe Capital Preservation Plans - Newser
Hologic Inc Stock (HOLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):